Table 8.
Severity Score | Non-transfused | Transfused | p value |
---|---|---|---|
AUC | AUC | ||
PRISM III | 0.91 (0.84–0.97) | 0.89 (0.83–0.95) | 0.74 |
PIM2 | 0.93 (0.89–0.97) | 0.88 (0.82–0.94) | 0.19 |
Day 1 PELOD | 0.92 (0.86–0.98) | 0.90 (0.84–0.95) | 0.61 |
LR+ (95 % CI) | LR+ (95 % CI) | ||
PRISM III | 471 (166–1332) | 64 (23–176) | 0.007 |
PIM2 | 471 (167–1333) | 38 (15–97) | 0.0004 |
Day 1 PELOD | 314 (120–825) | 53 (18–143) | 0.01 |
LR− (95 % CI) | LR− (95 % CI) | ||
PRISM III | 0.57 (0.44–0.74) | 0.39 (0.25–0.59) | 0.12 |
PIM2 | 0.57 (0.44–0.74) | 0.55 (0.41–0.74) | 0.84 |
Day 1 PELOD | 0.64 (0.51–0.81) | 0.52 (0.38–0.72) | 0.28 |
AUC area under the curve from a receiver operating characteristic (ROC) analysis; LR+ positive likelihood ratio, LR− negative likelihood ratio; CI confidence interval